Weight loss eludes you despite you eating right and exercising daily. Medications that may be associated with weight gain include antidepressants, steroids, diabetes medications, mood stabilizers, blood pressure medications, seizure medications, migraine
During a 3-year follow-up period, the average BMI increase was 0.37 kg/m2in women taking at least one weight-promoting medication, compared with an average increase of 0.27 kg/m2in women not taking such medications (P= .0045). Weight-promoting medications in the study included antidepressants...
if you're up late, the odds are greater that you're doing some late-night snacking, which means more calories. The other reason involves what's going on in your body when you're sleep-deprived. Changes in hormone levels increase hunger and appetite and also make you feel not as full ...
Only 1% used any AOM, and 14% used at least one weight‐loss‐promoting medication. We found that 36% used at least one weight‐gain‐promoting medication, and approximately 20% used multiple weight‐gain‐promoting medications. While AOMs are underutilized by participants with overweight/o...
These medications have been very popular; however, a randomized study of 822 patients (mean weight, 97 kg) found that dexfenfluramine led to a mean weight loss of only 9.8 kg versus 7.2 kg with placebo, although twice as many dexfenfluramine patients lost at least 10 kg.2 Another study...
The exact mechanism through which alemtuzumab leads to ICH remains uncertain, but one theory points to the drug's potential effect on blood pressure. Research has shown that there's an average increase in mean systolic and diastolic blood pressure (SBP and DBP) of about 20 mmHg and 6 mmHg,...
Today’s AOMs reliably help people lose 3% to 10% or more—as much as 22.5%—of their total body weight. That’s significant, because a loss in this range, especially as you get towards 10%, is known to bring a bevy of health improvements, including a reduction in various heart-relate...
Obesity is a chronic disease that has many causes. Treatment is aimed at palliation—that is, producing and maintaining weight loss. Regardless of the primary site of action, the net effect must be a reduction in food intake or increase in energy expenditure. 展开 ...
A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased risk of thyroid cancer. Jan 13, 2025 0 0 Medications Clinical trial highlights promising new treatment for intestinal worms ...
stimulant drugs for ADHD do not increase the risk of drug abuse. In fact, kids with ADHD who don't get treated are more likely to abuse alcohol or drugs as adults. But kids with conduct disorders may be more likely than others to abuse substances as they get older. That’s something ...